论文部分内容阅读
目的评价盐酸氨溴索治疗老年慢性支气管炎的临床疗效。方法 94例老年慢性支气管炎患者,随机分为观察组和对照组,各47例。观察组患者在常规疗法基础上联合盐酸氨溴索雾化吸入治疗,对照组患者仅选用常规疗法治疗,观察并比较两组患者临床疗效以及各症状消失时间。结果观察组治疗优良率为95.7%,明显高于对照组的76.6%,差异有统计学意义(P<0.05);观察组患者咳嗽、咳痰、肺部啰音等临床症状消退时间均明显短于对照组,差异有统计学意义(P<0.05)。结论盐酸氨溴索雾化吸入辅助治疗老年慢性支气管炎的临床疗效好,能明显减轻患者咳嗽、咳痰症状,值得在临床上予以推广。
Objective To evaluate the clinical efficacy of ambroxol hydrochloride in the treatment of chronic bronchitis in the elderly. Methods 94 elderly patients with chronic bronchitis were randomly divided into observation group and control group, 47 cases in each. Patients in the observation group were treated with inhalation of ambroxol hydrochloride inhalation on the basis of conventional therapy. Patients in the control group were treated with conventional therapy only. The clinical efficacy and the disappearance of each symptom were observed and compared between the two groups. Results The excellent and good rate of observation group was 95.7%, which was significantly higher than that of the control group (76.6%), the difference was statistically significant (P <0.05). The clinical symptoms such as cough, expectoration and pulmonary rales in the observation group were significantly shorter In the control group, the difference was statistically significant (P <0.05). Conclusion Ambroxol Hydrochloride inhalation assisted the treatment of senile chronic bronchitis with good clinical curative effect, which can obviously relieve the symptoms of cough and sputum and deserve to be popularized clinically.